Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC61532 CCI-007

    2-(4-((2-氨基-4-氧代噻唑-5(4H)-亚基)甲基)-2-甲氧基苯氧基)乙酸乙酯

    CCI-007 is a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.
  3. GC61524 SC-43 An SHP-1 activator
  4. GC61492 SW106065

    N-(吡啶-3-基)噻吩-2-羧酰胺

    SW-106065 is an apoptosis inducer in malignant peripheral nerve sheath tumors (MPNST), which can inhibit ATP consumption of sporadic MPNST and other models of MPNST with an EC50 of 1 ?M.
  5. GC61466 DMU-212

    3,4,5,4'-四甲氧基二苯乙烯

    DMU-212 is a methylated derivative of Resveratrol, with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities, which can induce mitotic arrest via induction of apoptosis and activation of extracellular-signal-regulated kinase1/2 (ERK1/2) protein.
  6. GC61461 SLF TFA SLFTFA是FK506结合蛋白(FKBP)的合成配体,对FKBP51的亲和力为3.1μM,对FKBP12的IC50为2.6μM,可用于合成PROTAC分子。
  7. GC61437 (E)-Methyl 4-coumarate

    4-羟基肉桂酸甲酯; Methyl trans-p-coumarate

    A phenol with diverse biological activities
  8. GC61436 Gallic acid hydrate

    没食子酸-水合物; 3,4,5-Trihydroxybenzoic acid hydrate

    A phenol with diverse biological activities
  9. GC61419 Dibenzoylmethane

    二苯甲酰甲烷

    Dibenzoylmethane是甘草中的次要成分,可激活Nrf2并预防各种癌症和氧化损伤。Dibenzoylmethane是姜黄素的类似物,会引起Keap1解离和Nrf2的核易位。
  10. GC61414 ICCB280

    (E)-2-(3,4-二羟基苯乙烯基)-3-(2-甲氧基苯基)喹唑啉-4(3H)-酮

    ICCB280是一种有效的C/EBPα诱导剂。ICCB280通过激活C/EBPα并影响其下游靶点(例如C/EBPε,G-CSFR和c-Myc),具有抗白血病特性,包括终末分化,增殖停滞和凋亡。
  11. GC19607 Raddeanin A

    竹节香附素A

    Raddeanin A 是海葵 raddeana 的天然三萜皂苷成分,具有抗癌活性。 Raddeanin A 通过 ROS/JNK 和 NF-κB 信号通路对人骨肉瘤发挥抗癌作用。
  12. GC19528 1,4-Benzoquinone

    对苯醌

    A toxic metabolite of benzene
  13. GC48920 β-Carboline-1-carboxylic Acid

    1-Formic Acid-β-carboline

    An alkaloid with diverse biological activities
  14. GC48919 Piliformic Acid A fungal metabolite
  15. GC48907 Metaxalone-d6

    AHR438-d6; NSC170959-d6

    An internal standard for the quantification of metaxalone
  16. GC48900 Isocurcumenol

    异莪术烯醇

    A sesquiterpene with diverse biological activities
  17. GC48893 Carbazomycin B A bacterial metabolite with diverse biological activities
  18. GC48878 Carbazomycin A A bacterial metabolite with diverse biological activities
  19. GC48850 Carbazomycin C A bacterial metabolite with diverse biological activities
  20. GC48848 Albendazole-d7

    阿苯达唑-D7,SKF-62979-d7

    An internal standard for the quantification of albendazole
  21. GC48839 Nifuroxazide-d4

    硝呋齐特 d4

    An internal standard for the quantification of nifuroxazide
  22. GC48831 Flutamide-d7

    SCH 13521-d7

    Flutamide-d7 是氘标记的氟他胺。
  23. GC48827 Flufenamic Acid-d4

    FFA-d4, Fluphenamic Acid-d4

    An internal standard for the quantification of flufenamic acid
  24. GC48826 Carbazomycin D A bacterial metabolite with diverse biological activities
  25. GC48774 Melicopine An acridone alkaloid with antimalarial and anticancer activities
  26. GC48711 Trypacidin A fungal metabolite
  27. GC48701 QD-394 An inducer of ROS production
  28. GC48689 SBP-7455 A dual inhibitor of ULK1 and ULK2
  29. GC48676 Monascuspiloin

    Monascinol

    A fungal metabolite with anticancer activity
  30. GC48667 Nanangenine C A drimane sesquiterpene
  31. GC48660 Nanangenine F A drimane sesquiterpene
  32. GC48652 Olomoucine II

    2-[[[2-[[(1R)-1-(羟基甲基)丙基]氨基]-9-(1-甲基乙基)-9H-嘌呤-6-基]氨基]甲基]苯酚

    A CDK inhibitor
  33. GC48619 Nanangenine B A drimane sesquiterpene
  34. GC48618 Isonanangenine B

    SF002-96-1

    A drimane sesquiterpene lactone
  35. GC48609 Nanangenine G A drimane sesquiterpene
  36. GC48580 Penicolinate B

    Penicolinate A monomethyl ester

    A fungal metabolite with diverse biological activities
  37. GC48533 Vanoxonin

    Antibiotic MG 245CF2A

    A bacterial metabolite
  38. GC48520 Betulonaldehyde

    白桦脂醛,半合成

    A pentacyclic triterpenoid
  39. GC48507 Kaempferol 3-O-galactoside

    三叶豆苷,Trifolin

    A flavonoid with diverse biological activities
  40. GC48504 Betulinic Aldehyde oxime

    桦木醛肟,半合成

    A derivative of betulin
  41. GC48497 Conglobatin C1 A bacterial metabolite
  42. GC48493 PCI 45227

    依鲁替尼代谢物,PCI-45227

    An active metabolite of ibrutinib
  43. GC48483 Conglobatin B A bacterial metabolite
  44. GC48482 28-Acetylbetulin

    28-acetoxy Betulin, 28-O-Acetylbetulin, C-28-Acetylbetulin

    A lupane triterpenoid with anti-inflammatory and anticancer activities
  45. GC48479 Migrastatin

    (+)-Migrastatin

    A fungal metabolite with antimuscarinic and anticancer activities
  46. GC48477 Betulinic Acid propargyl ester An alkyne derivative of betulinic acid
  47. GC48470 Ac-DEVD-CHO (trifluoroacetate salt)

    N-Ac-Asp-Glu-Val-Asp-CHO

    A dual caspase-3/caspase-7 inhibitor
  48. GC48451 N-(2-Azidoethyl)betulonamide A pentacyclic triterpenoid intermediate
  49. GC48449 28-(Poc-amino)betulin An alkyne derivative of betulin
  50. GC48442 Tryptoquivaline D

    Nortryptoquivaline, NSC 292204

    A fungal metabolite with anticancer activity
  51. GC48437 4'-Acetyl Chrysomycin A A bacterial metabolite with antibacterial and anticancer activities

Items 801 to 850 of 2733 total

per page

Set Descending Direction